Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations…
Hybrid Work Strategies: 3 Tips to Transform Engagement
In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation,…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had…
Find Your Own Light
It’s no secret that the last few years have been hard on just about everyone. COVID, climate change, political strife…
Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as…
Professionalism Still Matters
Sadly, another summer is coming to a close. If you have school-aged kids at home, you are undoubtedly already taking…
Communicating Without a Communications Leader
Many of our clients are emerging companies striving towards their first clinical development program in anticipation of…
Rare Diseases — It’s All About the Patient
Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th…
